Daniel R Wagner

Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.

D. Wagner, M. Vaillant, D. Rouy, 2006, Journal of cardiac failure.

Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrest.

Yvan Devaux, Y. Devaux, D. Wagner, 2013, Journal of the American College of Cardiology.

Information encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarction

Lu Zhang, Yvan Devaux, F. Azuaje, 2011, BMC Medical Genomics.

Adenosine Inhibits Matrix Metalloproteinase-9 Secretion By Neutrophils: Implication of A2a Receptor and cAMP/PKA/Ca2+ Pathway

Yvan Devaux, Y. Devaux, D. Wagner, 2006, Circulation research.

Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease

Jan A Staessen, Stephane Heymans, Tatiana Kuznetsova, 2010, Circulation. Cardiovascular genetics.

Playing Hide and Seek with Adenosine Receptors

Yvan Devaux, Y. Devaux, D. Wagner, 2008, Clinical and translational science.

miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?

Yvan Devaux, Y. Devaux, D. Wagner, 2014, Trends in molecular medicine.